ReviewJournal of nanobiotechnology2025
Constructing biomimetic microenvironments for liver regeneration.
Review in Journal of nanobiotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Guiding of Cell Migration over Sloped Steps Using TiOJournal of functional biomaterials · 2026Article
- SAA/FPR2 Signaling Between Pericentral Hepatocytes and Macrophages Exacerbates Zonated Liver Transplant Injury.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Robust generation of distal respiratory airway organoids by an engineered cuboid chip.Journal of nanobiotechnology · 2026Article
- Organ-on-chip (OoC) and nano-biomaterials: next generation of precision oral and dental healthcare research.Journal of nanobiotechnology · 2026Review
- Three-dimensional bioprinted hiHeps hepatorganoids with enhanced hepatic functions for the treatment of liver failure and promotion of liver regeneration.Bioactive materials · 2026Article
- Next-Generation Hydrogels for Biliary Organoid Engineering.Pharmaceuticals (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Liver regeneration is a sophisticated biological process influenced by a complex microenvironment that becomes profoundly altered in various pathological conditions. Current therapeutic approaches, including liver transplantation and pharmacological interventions, face significant limitations such as donor shortages, high costs, immune rejection, and insufficient functional recovery. Thus, alternative and innovative strategies are urgently needed. Biomimetic microenvironments constructed through tissue engineering have emerged as promising platforms, capable of recapitulating the liver's natural architecture and supporting hepatic cell functions. This review outlines key pathological features and the biological basis underlying liver regeneration, highlighting cellular plasticity, inflammation, extracellular matrix (ECM) remodeling, and immune interactions. It further discusses advanced biomimetic strategies, including 3D cell cultures, decellularized ECM hydrogels, bioprinting technologies, and dynamic culture systems like hollow fiber, fluidized-bed, and microcarrier bioreactors. These innovations facilitate accurate modeling of hepatic functions, maintain cellular differentiation, and enhance regeneration. Despite significant advancements, challenges remain in optimizing microenvironmental fidelity, ensuring clinical scalability, and translating laboratory breakthroughs into effective therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.